NHS adviser Sir Stuart Rose has private health link
Your support helps us to tell the story
This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
The former Marks & Spencer’s boss appointed by Jeremy Hunt to advise on improving the NHS could “make a fortune” from hospital takeovers by private companies, the country’s biggest union has claimed.
Sir Stuart Rose, who will lead a review of management in the NHS, is also paid to sit on the advisory board of Bridgepoint, an international private equity group, which is the major shareholder of private health firm Care UK.
Care UK is in the running to take over the George Eliot NHS Hospital Trust – one of 14 hospital trusts in Sir Stuart’s review. Rachael Maskell, national officer for health at the Unite union, said Sir Stuart’s appointment represented a “gobsmacking conflict of interest” and called on him to confirm he would not profit personally from Care UK’s bid for the Warwickshire hospital.
A Department of Health spokesperson said that Sir Stuart had “committed to recuse himself from any relevant health discussions at Bridgepoint European Advisory Board meetings”.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments